医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
ノート
院外処方せんに表示した臨床検査値に関する疑義照会内容の解析
佐野 梓末次 王卓秦 晃二郎柊迫 美咲片山 美幸田中 瑠美田島 壮一郎グリム 理恵子辻 敏和渡邊 裕之金谷 朗子増田 智先
著者情報
ジャーナル フリー

2018 年 44 巻 5 号 p. 229-235

詳細
抄録

We have disclosed 14 standardized laboratory data on out-of-hospital prescriptions since June 2015. In this study, we analyzed questions on out-of-hospital prescriptions related to laboratory data over 2 years. There were 229 prescription questions related to laboratory data (3.4% of the total prescription questions), and 79.5% of these were related to renal function. Among renal function-associated laboratory data, serum creatinine was used in most cases. The rate of prescription change after prescription questions was 66.5% for laboratory data associated with renal function, which was significantly higher (P < 0.001) than the 25.5% for other types of data. Furthermore, the clear description of dose reduction requirements on a package insert was confirmed to be one of the common factors for renal excretory drugs. Therefore, it is important to provide renal function laboratory data to facilitate the appropriate adjustment of out-of-hospital prescription doses. In addition, to enable appropriate dose adjustments using laboratory data, the description on the drug package insert should make it easy for pharmacists who are auditing prescriptions to make appropriate judgments.

著者関連情報
© 2018 日本医療薬学会
前の記事 次の記事
feedback
Top